Clorox (CLX) Scheduled to Post Quarterly Earnings on Wednesday

Clorox (NYSE:CLX) will be issuing its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $1.36 per share for the quarter. Clorox has set its FY25 guidance at $6.55-$6.80 EPS and its FY 2025 guidance at 6.550-6.800 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Stock Down 0.7 %

Shares of NYSE CLX opened at $159.23 on Wednesday. Clorox has a 12-month low of $114.68 and a 12-month high of $169.09. The stock has a market cap of $19.77 billion, a PE ratio of 82.50, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The company has a 50-day moving average of $159.96 and a 200 day moving average of $145.33.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.06%. Clorox’s dividend payout ratio (DPR) is 252.85%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CLX shares. Barclays increased their price target on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research note on Friday, October 11th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. TD Cowen started coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Finally, Citigroup upped their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $150.14.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.